These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Dohn M, Zhang S, Chen X. Oncogene; 2001 May 31; 20(25):3193-205. PubMed ID: 11423969 [Abstract] [Full Text] [Related]
4. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K, Tokino T. Gene Ther; 2001 Sep 31; 8(18):1401-8. PubMed ID: 11571580 [Abstract] [Full Text] [Related]
9. p53 leans on its siblings. Urist M, Prives C. Cancer Cell; 2002 May 13; 1(4):311-3. PubMed ID: 12086844 [Abstract] [Full Text] [Related]
10. FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression. Zhang J, Kong X, Zhang Y, Sun W, Wang J, Chen M, Chen X. J Pathol; 2020 Jul 13; 251(3):284-296. PubMed ID: 32304229 [Abstract] [Full Text] [Related]
11. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T. Nature; 2002 Apr 04; 416(6880):560-4. PubMed ID: 11932750 [Abstract] [Full Text] [Related]
12. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin. Ichikawa W, Ooyama A, Toda E, Sugimoto Y, Oka T, Takahashi T, Shimizu M, Sasaki Y, Hirayama R. Cancer Chemother Pharmacol; 2006 Dec 04; 58(6):794-801. PubMed ID: 16528528 [Abstract] [Full Text] [Related]
13. p63 and p73 are not required for the development and p53-dependent apoptosis of T cells. Senoo M, Manis JP, Alt FW, McKeon F. Cancer Cell; 2004 Jul 04; 6(1):85-9. PubMed ID: 15261144 [Abstract] [Full Text] [Related]
14. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Di Como CJ, Gaiddon C, Prives C. Mol Cell Biol; 1999 Feb 04; 19(2):1438-49. PubMed ID: 9891077 [Abstract] [Full Text] [Related]
15. Identification of new p53 target microRNAs by bioinformatics and functional analysis. Bisio A, De Sanctis V, Del Vescovo V, Denti MA, Jegga AG, Inga A, Ciribilli Y. BMC Cancer; 2013 Nov 21; 13():552. PubMed ID: 24256616 [Abstract] [Full Text] [Related]
16. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells. Ishida S, Yamashita T, Nakaya U, Tokino T. Jpn J Cancer Res; 2000 Feb 21; 91(2):174-80. PubMed ID: 10761704 [Abstract] [Full Text] [Related]
17. ING1b decreases cell proliferation through p53-dependent and -independent mechanisms. Tsang FC, Po LS, Leung KM, Lau A, Siu WY, Poon RY. FEBS Lett; 2003 Oct 23; 553(3):277-85. PubMed ID: 14572637 [Abstract] [Full Text] [Related]
18. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor. Spiesbach K, Tannapfel A, Mössner J, Engeland K. Int J Cancer; 2005 Apr 20; 114(4):555-62. PubMed ID: 15578720 [Abstract] [Full Text] [Related]
19. Transcriptional regulation of human ferredoxin reductase through an intronic enhancer in steroidogenic cells. Imamichi Y, Mizutani T, Ju Y, Matsumura T, Kawabe S, Kanno M, Yazawa T, Miyamoto K. Biochim Biophys Acta; 2014 Jan 20; 1839(1):33-42. PubMed ID: 24321386 [Abstract] [Full Text] [Related]
20. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. Dietz S, Rother K, Bamberger C, Schmale H, Mössner J, Engeland K. FEBS Lett; 2002 Aug 14; 525(1-3):93-9. PubMed ID: 12163168 [Abstract] [Full Text] [Related] Page: [Next] [New Search]